115 related articles for article (PubMed ID: 2125362)
1. Enhancement of complement activation and cytolysis of human IgG3 by deletion of hinge exons.
Michaelsen TE; Aase A; Westby C; Sandlie I
Scand J Immunol; 1990 Nov; 32(5):517-28. PubMed ID: 2125362
[TBL] [Abstract][Full Text] [Related]
2. Activation of complement by an IgG molecule without a genetic hinge.
Brekke OH; Michaelsen TE; Sandin R; Sandlie I
Nature; 1993 Jun; 363(6430):628-30. PubMed ID: 8510754
[TBL] [Abstract][Full Text] [Related]
3. Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse-human IgG subclasses and IgG3 antibodies with altered hinge region.
Michaelsen TE; Aase A; Norderhaug L; Sandlie I
Mol Immunol; 1992 Mar; 29(3):319-26. PubMed ID: 1557042
[TBL] [Abstract][Full Text] [Related]
4. Chimeric mouse human IgG3 antibodies with an IgG4-like hinge region induce complement-mediated lysis more efficiently than IgG3 with normal hinge.
Norderhaug L; Brekke OH; Bremnes B; Sandin R; Aase A; Michaelsen TE; Sandlie I
Eur J Immunol; 1991 Oct; 21(10):2379-84. PubMed ID: 1915551
[TBL] [Abstract][Full Text] [Related]
5. C1q binding to chimeric monoclonal IgG3 antibodies consisting of mouse variable regions and human constant regions with shortened hinge containing 15 to 47 amino acids.
Sandlie I; Aase A; Westby C; Michaelsen TE
Eur J Immunol; 1989 Sep; 19(9):1599-603. PubMed ID: 2792180
[TBL] [Abstract][Full Text] [Related]
6. One disulfide bond in front of the second heavy chain constant region is necessary and sufficient for effector functions of human IgG3 without a genetic hinge.
Michaelsen TE; Brekke OH; Aase A; Sandin RH; Bremnes B; Sandlie I
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9243-7. PubMed ID: 7937748
[TBL] [Abstract][Full Text] [Related]
7. Structural difference in the complement activation site of human IgG1 and IgG3.
Michaelsen TE; Sandlie I; Bratlie DB; Sandin RH; Ihle O
Scand J Immunol; 2009 Dec; 70(6):553-64. PubMed ID: 19906198
[TBL] [Abstract][Full Text] [Related]
8. Human IgG1, IgG3, and IgG3 Hinge-Truncated Mutants Show Different Protection Capabilities against Meningococci Depending on the Target Antigen and Epitope Specificity.
Giuntini S; Granoff DM; Beernink PT; Ihle O; Bratlie D; Michaelsen TE
Clin Vaccine Immunol; 2016 Aug; 23(8):698-706. PubMed ID: 27307451
[TBL] [Abstract][Full Text] [Related]
9. The IGHG3 gene shows a structural polymorphism characterized by different hinge lengths: sequence of a new 2-exon hinge gene.
Dard P; Huck S; Frippiat JP; Lefranc G; Langaney A; Lefranc MP; Sanchez-Mazas A
Hum Genet; 1997 Jan; 99(1):138-41. PubMed ID: 9003512
[TBL] [Abstract][Full Text] [Related]
10. Human IgG3 can adopt the disulfide bond pattern characteristic for IgG1 without resembling it in complement mediated cell lysis.
Brekke OH; Bremnes B; Sandin R; Aase A; Michaelsen TE; Sandlie I
Mol Immunol; 1993 Nov; 30(16):1419-25. PubMed ID: 8232327
[TBL] [Abstract][Full Text] [Related]
11. Solution conformation of wild-type and mutant IgG3 and IgG4 immunoglobulins using crystallohydrodynamics: possible implications for complement activation.
Lu Y; Harding SE; Michaelsen TE; Longman E; Davis KG; Ortega A; Grossmann JG; Sandlie I; García de la Torre J
Biophys J; 2007 Dec; 93(11):3733-44. PubMed ID: 17704171
[TBL] [Abstract][Full Text] [Related]
12. Activation of complement by human IgG1 and human IgG3 antibodies against the human leucocyte antigen CD52.
Redpath S; Michaelsen T; Sandlie I; Clark MR
Immunology; 1998 Apr; 93(4):595-600. PubMed ID: 9659234
[TBL] [Abstract][Full Text] [Related]
13. The structural requirements for complement activation by IgG: does it hinge on the hinge?
Brekke OH; Michaelsen TE; Sandlie I
Immunol Today; 1995 Feb; 16(2):85-90. PubMed ID: 7888072
[TBL] [Abstract][Full Text] [Related]
14. A mutant human IgG molecule with only one C1q binding site can activate complement and induce lysis of target cells.
Michaelsen TE; Thommesen JE; Ihle O; Gregers TF; Sandin RH; Brekke OH; Sandlie I
Eur J Immunol; 2006 Jan; 36(1):129-38. PubMed ID: 16323243
[TBL] [Abstract][Full Text] [Related]
15. The extended hinge region of IgG3 is not required for high phagocytic capacity mediated by Fc gamma receptors, but the heavy chains must be disulfide bonded.
Aase A; Sandlie I; Norderhaug L; Brekke OH; Michaelsen TE
Eur J Immunol; 1993 Jul; 23(7):1546-51. PubMed ID: 8325331
[TBL] [Abstract][Full Text] [Related]
16. Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins.
Tan LK; Shopes RJ; Oi VT; Morrison SL
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):162-6. PubMed ID: 2296577
[TBL] [Abstract][Full Text] [Related]
17. Different glycosylation pattern of human IgG1 and IgG3 antibodies isolated from transiently as well as permanently transfected cell lines.
Vestrheim AC; Moen A; Egge-Jacobsen W; Bratlie DB; Michaelsen TE
Scand J Immunol; 2013 May; 77(5):419-28. PubMed ID: 23488770
[TBL] [Abstract][Full Text] [Related]
18. A gamma 3 hinge region probe: first specific human immunoglobulin subclass probe.
Huck S; Keyeux G; Ghanem N; Lefranc MP; Lefranc G
FEBS Lett; 1986 Nov; 208(2):221-30. PubMed ID: 2877902
[TBL] [Abstract][Full Text] [Related]
19. Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies.
Dangl JL; Wensel TG; Morrison SL; Stryer L; Herzenberg LA; Oi VT
EMBO J; 1988 Jul; 7(7):1989-94. PubMed ID: 3138110
[TBL] [Abstract][Full Text] [Related]
20. Baboon immunoglobulin constant region heavy chains: identification of four IGHG genes.
Attanasio R; Jayashankar L; Engleman CN; Scinicariello F
Immunogenetics; 2002 Nov; 54(8):556-61. PubMed ID: 12439618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
